Atrial fibrillation is a common type of irregular heartbeat in which the heart’s two upper chambers (atria) begin to beat too rapidly. As a result, the heart’s upper and lower chambers (ventricles) fail to work together, causing blood to pool in atria. This can produce blood clots that travel from the heart to brain, where they cause a stroke. The condition is difficult to diagnose since it often occurs for short durations and ends before the person can make it to a doctor’s office or a hospital for an electrocardiogram (ECG) evaluation.
Researchers from the Technology Research Centre (TRC), University of Turku, Finland, have developed a smartphone-based method of detecting Atrial fibrillation using a smoothing and specially designed algorithm. Researchers found they could place a smartphone on a patient’s chest while they were lying down and then use the phone’s accelerometer and gyroscope, to detect the rapid beating that’s indicative of AF.
“We measure the actual motion of the heart via miniature accelerometers and gyroscopes that are already installed in today’s smartphones,” said lead author Tero Koivisto. “No additional hardware is needed, and people just need to install an app with the algorithm we developed.”
In a trial with 16 atrial fibrillation patients and 20 healthy patients, the smartphone app was able to detect. The atrial method was able to detect atrial fibrillation in 95 percent of the cases. The team hopes doctors and patients will adopt this technology and use it as an affordable way to monitor for atrial fibrillation. The team also foresees a future where a cloud component will store these recording and be utilized for a population-wide analysis of atrial fibrillation cases.
Editors' Recommendations
- Fitbit study could detect atrial fibrillation without ECG, and you can sign up
- It’s all in the wrist: Wearables are helping to treat disease and disability
- Brainwave-reading temporary tattoos could take wearable tech to the next level
- All the COVID-19 treatments currently in clinical trials
- FDA clears heart monitor for coronavirus patients using hydroxychloroquine
